Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47
Time to optimise novel cell-based mRNA therapeutics reduced by more than 90%
New hypertension pill gets FDA approval
Sofinnova Partners and NVIDIA look to accelerate European life sciences startups
I-Corps Hub West accelerates deeptech commercialisation in western US
Stargardt disease targeted with $135m SpliceBio financing
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
Base to Base biotech podcast 12: CLS boosts drug discovery capabilities and Sitryx – pioneers in immunometabolism